Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity

Immunotherapy of cancer with checkpoint inhibitors has been associated with a spectrum of autoimmune and systemic inflammatory reactions known as immune-related adverse events (irAEs). Rheumatic irAEs are infrequently reported and extensively described. Here, we report our experience over an 18-mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, C, Kirchner, E, Kontzias, K, Velcheti, V, Calabrese, L H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372131/
https://www.ncbi.nlm.nih.gov/pubmed/28405474
http://dx.doi.org/10.1136/rmdopen-2016-000412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372131/
https://www.ncbi.nlm.nih.gov/pubmed/28405474
http://dx.doi.org/10.1136/rmdopen-2016-000412

Ejemplares similares